-
-
-
公开(公告)号：US11571507B2
公开(公告)日：2023-02-07
申请号：US17039003
申请日：2020-09-30
申请人： BETA BIONICS, Inc.
发明人： Edward R. Damiano , David Matthew Henderson , Bryan Dale Knodel , Michael J. Rosinko , Justin P. Brown , Todd S. Ray , Mads Henrik Dall , David Chi-Wai Lim
摘要： Certain embodiments provide multi-medicament or single medicament infusion systems for preventing the cross-channeling or improper delivery of medicaments. The system may include one or more of an infusion pump, medicament cartridges, cartridge connectors, a multi-channel fluid conduit, and an infusion set. The medicament cartridges may be sized and shaped differently such that the medicament reservoirs can only be inserted into the pump under selected configurations.
-
公开(公告)号：US20220118179A1
公开(公告)日：2022-04-21
申请号：US17482281
申请日：2021-09-22
申请人： Beta Bionics, Inc.
发明人： Michael J. Rosinko , Edward R. Damiano , David Chi-Wai Lim , Firas H. El-Khatib , Justin P. Brown , Bryan Dale Knodel
IPC分类号： A61M5/172 , G16H20/17 , G16H40/40 , G06F8/656 , H04W76/10 , A61M5/142 , G06F8/61 , H04L67/00 , G16H40/60 , G16H80/00 , A61M5/168 , G08B21/04 , G08B21/18 , G16H40/67 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G16H10/60 , G16H50/30 , G06F3/04883 , G06F8/65 , H04W76/14 , H04L9/08 , H04L9/30 , G06F3/04847
摘要： Systems and methods are disclosed herein for updating an application controlling an ambulatory medical device such that application updates can be identified, downloaded and installed without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device may receive an indication that an update to an application executing on the ambulatory insulin pump is available, establish a communication connection to a host computing system configured to host the application update, and download the application update. The disclosed systems and methods can determine an execution time of an installation and install the downloaded application update without interrupting therapy provided by the ambulatory medical device to the subject.
-
公开(公告)号：US11123485B2
公开(公告)日：2021-09-21
申请号：US17062361
申请日：2020-10-02
申请人： Beta Bionics, Inc.
发明人： Himanshu Patel , Michael J. Rosinko , Edward R. Damiano , David Chi-Wai Lim , Firas H. El-Khatib , John R. Costik , Justin P. Brown , Bryan Dale Knodel
IPC分类号： A61M5/172 , G16H20/17 , G16H40/40 , G06F8/656 , H04W76/10 , A61M5/142 , G06F8/61 , G16H40/60 , G16H80/00 , A61M5/168 , G08B21/04 , G08B21/18 , G16H40/67 , H04L29/08 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G16H10/60 , G16H50/30 , G06F3/0488 , G06F8/65 , H04L29/06 , H04W76/14 , H04L9/08 , H04L9/30 , G06F3/0484 , G08B25/00 , A61B5/145 , G16H40/00
摘要： Systems and methods are disclosed herein for switching an application executing on an ambulatory medical device to a new application without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device may receive an indication that an update to an application executing on the ambulatory insulin pump is available, establish a communication connection to a host computing system, download and install the application update, while a prior version of the application continues to run. The disclosed systems and methods can confirm successful installation of the application update on the ambulatory medical device and switch control of the ambulatory medical device from the prior version to the new version of the application without interrupting therapy provided to the subject.
-
公开(公告)号：US11103638B2
公开(公告)日：2021-08-31
申请号：US17062280
申请日：2020-10-02
申请人： Beta Bionics, Inc.
发明人： Michael J. Rosinko , Edward R. Damiano , David Chi-Wai Lim , Firas H. El-Khatib , Justin P. Brown , Bryan Dale Knodel
IPC分类号： A61M5/172 , A61M5/142 , G06F3/0484 , G06F3/0488 , G16H20/17 , G16H40/40 , G06F8/656 , H04W76/10 , G06F8/61 , H04L29/08 , G16H40/60 , G16H80/00 , A61M5/168 , G08B21/04 , G08B21/18 , G16H40/67 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G16H10/60 , G16H50/30 , G06F8/65 , H04L29/06 , H04W76/14 , H04L9/08 , H04L9/30 , G08B25/00 , A61B5/145 , G16H40/00
摘要： Systems and methods presented herein relate to cancelling a modification of medicament delivery initiated by a user. A display of a therapy control element can be generated on an interface, such as a touchscreen. The therapy control element permits a user to modify a control parameter used in a control algorithm for generating a dose control signal for delivering medicament to a subject. Responsive to receiving the modification, the control parameter may be modified at a first time from a first setting to a second setting based on an indication of the modification to the therapy control element. Responsive to receiving a restore gesture on the touchscreen at a second time, the control parameter may be restored back to the first setting. This restore gesture may be a swipe gesture performed by a user.
-
公开(公告)号：US20220096748A1
公开(公告)日：2022-03-31
申请号：US17492007
申请日：2021-10-01
申请人： Beta Bionics, Inc.
发明人： Firas H. El-Khatib , Edward R. Damiano , Edward B. Raskin , David Chi-Wai Lim , Michael J. Rosinko , John R. Costik
IPC分类号： A61M5/172 , G16H20/17 , G16H40/40 , G06F8/656 , H04W76/10 , A61M5/142 , G06F8/61 , H04L29/08 , G16H40/60 , G16H80/00 , A61M5/168 , G08B21/04 , G08B21/18 , G16H40/67 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G16H10/60 , G16H50/30 , G06F3/0488 , G06F8/65 , H04L29/06 , H04W76/14 , H04L9/08 , H04L9/30 , G06F3/0484
摘要： An automated blood glucose control system can provide automatic delivery of glucose control therapy to a subject and receive information about manual glucose control therapy provided to the subject. The automated blood glucose control system can indicate an amount of a bolus of medicament via a control algorithm configured to control blood glucose level in the subject. The automated blood glucose control system can indicate an amount of a manual bolus of medicament, which can be used to model a diminishment of the medicament in the subject over time based at least in part on the manual bolus of medicament.
-
公开(公告)号：US20220072227A1
公开(公告)日：2022-03-10
申请号：US17478071
申请日：2021-09-17
申请人： Beta Bionics, Inc.
发明人： Himanshu Patel , Michael J. Rosinko , Edward R. Damiano , David Chi-Wai Lim , Firas H. El-Khatib , John R. Costik , Justin P. Brown , Bryan Dale Knodel
IPC分类号： A61M5/172 , G16H20/17 , G16H40/40 , G06F8/656 , H04W76/10 , A61M5/142 , G06F8/61 , H04L29/08 , G16H40/60 , G16H80/00 , A61M5/168 , G08B21/04 , G08B21/18 , G16H40/67 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G16H10/60 , G16H50/30 , G06F3/0488 , G06F8/65 , H04L29/06 , H04W76/14 , H04L9/08 , H04L9/30 , G06F3/0484
摘要： Systems and methods are disclosed herein for switching an application executing on an ambulatory medical device to a new application without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device may receive an indication that an update to an application executing on the ambulatory insulin pump is available, establish a communication connection to a host computing system, download and install the application update, while a prior version of the application continues to run. The disclosed systems and methods can confirm successful installation of the application update on the ambulatory medical device and switch control of the ambulatory medical device from the prior version to the new version of the application without interrupting therapy provided to the subject.
-
公开(公告)号：US11154656B2
公开(公告)日：2021-10-26
申请号：US17062436
申请日：2020-10-02
申请人： Beta Bionics, Inc.
发明人： Firas H. El-Khatib , Edward R. Damiano , Edward B. Raskin , David Chi-Wai Lim , Michael J. Rosinko , John R. Costik
IPC分类号： A61M5/172 , A61M5/142 , G16H20/17 , G16H40/40 , G06F8/656 , H04W76/10 , G06F8/61 , H04L29/08 , G16H40/60 , G16H80/00 , A61M5/168 , G08B21/04 , G08B21/18 , G16H40/67 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G16H10/60 , G16H50/30 , G06F3/0488 , G06F8/65 , H04L29/06 , H04W76/14 , H04L9/08 , H04L9/30 , G06F3/0484 , G08B25/00 , A61B5/145 , G16H40/00
摘要： An automated blood glucose control system can provide automatic delivery of glucose control therapy to a subject and receive information about manual glucose control therapy provided to the subject. The automated blood glucose control system can indicate an amount of a bolus of medicament via a control algorithm configured to control blood glucose level in the subject. The automated blood glucose control system can indicate an amount of a manual bolus of medicament, which can be used to model a diminishment of the medicament in the subject over time based at least in part on the manual bolus of medicament.
-
公开(公告)号：US20210090726A1
公开(公告)日：2021-03-25
申请号：US17062356
申请日：2020-10-02
申请人： Beta Bionics, Inc.
发明人： Michael J. Rosinko , Edward R. Damiano , David Chi-Wai Lim , Firas H. El-Khatib , Himanshu Patel , John R. Costik , Justin P. Brown , Bryan Dale Knodel
摘要： Systems and methods are disclosed herein for updating an application controlling an ambulatory medical device such that application updates can be identified, downloaded and installed without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device may receive an indication that an update to an application executing on the ambulatory insulin pump is available, establish a communication connection to a host computing system configured to host the application update, and download the application update. The disclosed systems and methods can determine an execution time of an installation and install the downloaded application update without interrupting therapy provided by the ambulatory medical device to the subject.
-
-
-
-
-
-
-
-
-
搜索结果
45 条记录 (耗时 0.017 秒)
